首页>
外国专利>
SUMMARY FOR INCREASING THE NUMBER OF ANTI-PRESENTING CELLS AND ANSWERS IN HUMAN PATIENTS
SUMMARY FOR INCREASING THE NUMBER OF ANTI-PRESENTING CELLS AND ANSWERS IN HUMAN PATIENTS
展开▼
机译:增加人类患者抗感染细胞和应答的数量的摘要
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods for enhancing the development of APC from precursor cells by administering a combination of GM-CSF and IL-4. The precursor cells include: cells contained in peripheral blood, CD14+ cells and precursors in bone marrow. Thus, administration of GM-CSF and IL-4 can be used as a form of cytokine immunotherapy. One embodiment of the present invention involves systemic administration of GM-CSF and IL-4. In this embodiment, APC are required to directly access tumor antigens as they exist in vivo within the patient. A further embodiment of the present invention involves co-administration of a tumor-associated or tumor-specific antigen, with GM-CSF and IL-4, to induce antigen-specific immunity mediated by APC. Yet another embodiment of the present invention describes systemic administration of GM-CSF and IL-4 to achieve reduced tumor burden.
展开▼